Miguel Hueso Hospital Universitari Bellvitge, and Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet Llobregat

Home

Archive

About Us

JUAN TORRAS Departament de Ciencies Clíniques, Universitat de Barcelona BARCELONA
1 protocol

Josep Maria Aran Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, BARCELONA
2 protocols

Josep Maria Cruzado
1 protocol

Josep Maria Grinyo Department of Clinical Sciences. Bellvitge Campus. BARCELONA
1 protocol

Reviewer

Miguel Hueso

Faculty, Hospital Universitari Bellvitge, and Institut d’Investigació Biomèdica de Bellvitge-IDIBELL, L’Hospitalet de Llobregat

Research focus

Molecular biology
Dialysis, Cardiovascular disease, Molecular Medicine, Nanotechnology, Machine Learning

1 Author merit
Reviewer merit
Editor merit

Education

PhD, Barcelona, 2006

Publications

https://pubmed.ncbi.nlm.nih.gov/?term=hueso+m

1 Protocol published

In vivo CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney Immunostaining

Authors: Miguel Hueso, Adrián Mallén, Elia Ripoll, Laura de Ramón, Nuria Bolaños, Cristian Varela, Jordi Guiteras, Javier Checa, Estanislao Navarro, Josep Maria Grinyo, Josep Maria Cruzado, Josep Maria Aran and Joan Torras, date: 05/20/2021, view: 6134, Q&A: 0

The co-stimulatory molecule CD40 and its ligand CD40L play a key role in the regulation of immunological processes and are involved in the pathophysiology of autoimmune and inflammatory diseases. Inhibition of the CD40-CD40L axis is a promising

...

More >